Evidence map›Paper›PMID 32375838›Full record

ArticleJournal of neuroinflammation2020

IRE1α inhibition attenuates neuronal pyroptosis via miR-125/NLRP1 pathway in a neonatal hypoxic-ischemic encephalopathy rat model.

Juan Huang, Weitian Lu, Desislava Met Doycheva, Marcin Gamdzyk, Xiao Hu, Rui Liu, John H Zhang, Jiping Tang

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. The Role of the Interleukin-1 Family in Complications of Prematurity.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Juan HuangInstitute of Neuroscience, Chongqing Medical University, Chongqing, 400016, China.
Weitian LuInstitute of Neuroscience, Chongqing Medical University, Chongqing, 400016, China.
Desislava Met DoychevaDepartment of Physiology and Pharmacology, Loma Linda University, Risley Hall, 11041 Campus St, Loma Linda, CA, 92350, USA.
Marcin GamdzykDepartment of Physiology and Pharmacology, Loma Linda University, Risley Hall, 11041 Campus St, Loma Linda, CA, 92350, USA.
Xiao HuDepartment of Physiology and Pharmacology, Loma Linda University, Risley Hall, 11041 Campus St, Loma Linda, CA, 92350, USA.
Rui LiuDepartment of Physiology and Pharmacology, Loma Linda University, Risley Hall, 11041 Campus St, Loma Linda, CA, 92350, USA.
John H ZhangDepartment of Physiology and Pharmacology, Loma Linda University, Risley Hall, 11041 Campus St, Loma Linda, CA, 92350, USA.
Jiping TangDepartment of Physiology and Pharmacology, Loma Linda University, Risley Hall, 11041 Campus St, Loma Linda, CA, 92350, USA. jtang@llu.edu.
Loma Linda University · USGuizhou Provincial People's Hospital · CN

Funding

American Heart Association 17GRNT33670031
6 · The paper itself

Abstract

backgroundInhibition of inositol-requiring enzyme-1 alpha (IRE1α), one of the sensor signaling proteins associated with endoplasmic reticulum (ER) stress, has been shown to alleviate brain injury and improve neurological behavior in a neonatal hypoxic-ischemic encephalopathy (HIE) rat model. However, there is no information about the role of IRE1α inhibitor as well as its molecular mechanisms in preventing neuronal pyroptosis induced by NLRP1 (NOD-, LRR- and pyrin domain-containing 1) inflammasome. In the present study, we hypothesized that IRE1α can degrade microRNA-125-b-2-3p (miR-125-b-2-3p) and activate NLRP1/caspased-1 pathway, and subsequently promote neuronal pyroptosis in HIE rat model.

methodsTen-day old unsexed rat pups were subjected to hypoxia-ischemia (HI) injury, and the inhibitor of IRE1α, STF083010, was administered intranasally at 1 h after HI induction. AntimiR-125 or NLRP1 activation CRISPR was administered by intracerebroventricular (i.c.v) injection at 24 h before HI induction. Immunofluorescence staining, western blot analysis, reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR), brain infarct volume measurement, neurological function tests, and Fluoro-Jade C staining were performed.

resultsEndogenous phosphorylated IRE1α (p-IRE1α), NLRP1, cleaved caspase-1, interleukin-1β (IL-1β), and interleukin-18 (IL-18) were increased and miR-125-b-2-3p was decreased in HIE rat model. STF083010 administration significantly upregulated the expression of miR-125-b-2-3p, reduced the infarct volume, improved neurobehavioral outcomes and downregulated the protein expression of NLRP1, cleaved caspase-1, IL-1β and IL-18. The protective effects of STF083010 were reversed by antimiR-125 or NLRP1 activation CRISPR.

conclusionsIRE1α inhibitor, STF083010, reduced neuronal pyroptosis at least in part via miR-125/NLRP1/caspase-1 signaling pathway after HI.

Indexed as

AnimalsAnimals, NewbornDisease Models, AnimalEndoribonucleasesHypoxia-Ischemia, BrainInflammasomesMicroRNAsMultienzyme ComplexesNerve Tissue ProteinsNeuronsProtein Serine-Threonine KinasesPyroptosisRatsRats, Sprague-DawleySignal TransductionSulfonamidesEndoribonucleasesErn1 protein, ratInflammasomesMicroRNAsMIRN125 microRNA, ratMultienzyme ComplexesNerve Tissue ProteinsNlrp1a protein, ratProtein Serine-Threonine KinasesSTF 083010SulfonamidesThiophenesHypoxic-ischemic encephalopathyInflammasomeIRE1αmiR-125NLPR1Pyroptosis

Identifiers

PMID32375838
PMCPMC7203836
OpenAlexW3022006117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.